ZimVie Inc
NASDAQ:ZIMV
ZimVie Inc
Revenue
ZimVie Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Z
|
ZimVie Inc
NASDAQ:ZIMV
|
Revenue
$457.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is ZimVie Inc's Revenue?
Revenue
457.4m
USD
Based on the financial report for Dec 31, 2023, ZimVie Inc's Revenue amounts to 457.4m USD.
What is ZimVie Inc's Revenue growth rate?
Revenue CAGR 5Y
-16%
Over the last year, the Revenue growth was -50%. The average annual Revenue growth rates for ZimVie Inc have been -21% over the past three years , -16% over the past five years .